Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 202 participants.
Also called NCT01958320
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 202 participants
- Registry
-
NCT01958320
-
- Other papers using this trial's data
- Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320)
- PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Sweden, Türkiye, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01958320. Randomized; single masking; primary purpose treatment. Start 2013-12 (registry gives no type); primary completion 2017-06 (actual). Results posted on 2018-11-30.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
- Acronym
- PDA:TOLERATE
- Condition
- Patent Ductus Arteriosus
- Condition
- Surgery
- Condition
- Necrotizing Enterocolitis
- Condition
- Intestinal Perforation
- Intervention (Other)
- pharmacologic treatment of the PDA
- Intervention (Other)
- no pharmacologic treatment of the PDA
- Intervention (Drug)
- NSAID
- Lead sponsor
- University of California, San Francisco
Record details
- Record id
cardio:ct-nct01958320- Content hash
fdea38f9c7270b04763702265205fe276a88798dd7b60f01f0c1501fbb888c3d